Oncology drug suppliers like Fresenius Kabi, Sandoz, Teva, Dr. Reddy’s and Aurobindo are in the spotlight as they hold keys to solving a deepening cancer drugs shortage crisis in US, EU, Australia, Canada and India, amid originator brand discontinuations and structural issues